Question 1

What are the most cited papers from Polyclinique de Franche Comté?

Accepted Answer

The most cited paper from Polyclinique de Franche Comté is "Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials" (Alexa B. Kimball et al., 2023), with 332 citations. Next come "Stapled Hemorrhoidopexy Versus Milligan-Morgan Hemorrhoidectomy" (202) and "Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial" (167).

Question 2

Which research topics does Polyclinique de Franche Comté publish most on?

Accepted Answer

By volume in 2022-now: Dermatology and Skin Diseases, Hidradenitis Suppurativa and Treatments, Urticaria and Related Conditions and Shoulder Injury and Treatment.

Question 3

Which keywords describe research at Polyclinique de Franche Comté?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Quality of Life, Diagnosis, Management, Immunosuppressive Therapy, Autoantibodies, Autoimmune, Epidemiology and Staphylococcus aureus.

Question 4

Which fields of science does Polyclinique de Franche Comté work in?

Accepted Answer

In 2022-now, 88% of research at Polyclinique de Franche Comté is in Health Sciences, 6% in Life Sciences. Its largest fields are Medicine (82%), Health Professions (5%), Engineering (4%). It does 2.8× the world's share of Health Sciences.

Question 5

Is Polyclinique de Franche Comté's research output growing?

Accepted Answer

Output in 2022-2025 was 125% higher than in 2018-2021.